These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 3387352)
41. Current therapy of major fungal diseases of the lung. Johnson P; Sarosi G Infect Dis Clin North Am; 1991 Sep; 5(3):635-45. PubMed ID: 1955703 [TBL] [Abstract][Full Text] [Related]
43. Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group. Dismukes WE; Bradsher RW; Cloud GC; Kauffman CA; Chapman SW; George RB; Stevens DA; Girard WM; Saag MS; Bowles-Patton C Am J Med; 1992 Nov; 93(5):489-97. PubMed ID: 1332471 [TBL] [Abstract][Full Text] [Related]
44. Opportunistic fungal infections in patients with acquired immune deficiency syndrome. Viviani MA Chemotherapy; 1992; 38 Suppl 1():35-42. PubMed ID: 1319314 [TBL] [Abstract][Full Text] [Related]
45. Oral azole drugs as systemic antifungal therapy. Como JA; Dismukes WE N Engl J Med; 1994 Jan; 330(4):263-72. PubMed ID: 8272088 [TBL] [Abstract][Full Text] [Related]
46. [Guideline for diagnosis and treatment of deep mycosis]. Kono S Rinsho Ketsueki; 2001 Jun; 42(6):452-7. PubMed ID: 11505521 [No Abstract] [Full Text] [Related]
47. Itraconazole. Med Lett Drugs Ther; 1993 Jan; 35(888):7-9. PubMed ID: 8380485 [No Abstract] [Full Text] [Related]
48. Pulmonary invasive aspergillosis in patients infected with the human immunodeficiency virus: report of two cases. Mylonakis E; Mileno MD; Flanigan T; De Orchis DF; Rich J Heart Lung; 1998; 27(1):63-6. PubMed ID: 9493885 [TBL] [Abstract][Full Text] [Related]
49. Newer developments in therapy for endemic mycoses. Kauffman CA Clin Infect Dis; 1994 Aug; 19 Suppl 1():S28-32. PubMed ID: 7948568 [TBL] [Abstract][Full Text] [Related]
50. State-of-the-art review of pulmonary fungal infections. Wheat LJ; Goldman M; Sarosi G Semin Respir Infect; 2002 Jun; 17(2):158-81. PubMed ID: 12070835 [TBL] [Abstract][Full Text] [Related]
51. [Clinical features and treatment of invasive fungal infection in 47 patients with hematological malignancies]. Zhu Y; Chen SP; Shu YG; Xu YJ Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 33(1):89-92. PubMed ID: 18245913 [TBL] [Abstract][Full Text] [Related]
53. Modern concepts in the diagnosis and management of the pulmonary mycoses. Busey JF Clin Notes Respir Dis; 1976; 14(4):3-15. PubMed ID: 782753 [No Abstract] [Full Text] [Related]
54. Treatment of systemic mycoses with miconazole: a review. Symoens J; Amery W Mod Med Asia; 1977 Mar; 13(3):9-11. PubMed ID: 593251 [No Abstract] [Full Text] [Related]
55. Therapy of invasive aspergillosis with itraconazole: improvement of therapeutic efficacy by early diagnosis. Kreisel W; Köchling G; von Schilling C; Azemar M; Kurzweil B; Dölken G; Lindemann A; Blum U; Windfuhr M; Müller J Mycoses; 1991; 34(9-10):385-94. PubMed ID: 1668178 [TBL] [Abstract][Full Text] [Related]
56. Treatment of histoplasmosis and blastomycosis. Saag MS; Dismukes WE Chest; 1988 Apr; 93(4):848-51. PubMed ID: 3280262 [TBL] [Abstract][Full Text] [Related]
57. Itraconazole released for blastomycosis and histoplasmosis therapy. Clin Pharm; 1993 Jan; 12(1):6-7. PubMed ID: 8381341 [No Abstract] [Full Text] [Related]
58. Antifungal agents. Part II. The azoles. Terrell CL Mayo Clin Proc; 1999 Jan; 74(1):78-100. PubMed ID: 9987539 [TBL] [Abstract][Full Text] [Related]
59. Invasive pulmonary aspergillosis in neutropenic patients during hospital construction: before and after chemoprophylaxis and institution of HEPA filters. Oren I; Haddad N; Finkelstein R; Rowe JM Am J Hematol; 2001 Apr; 66(4):257-62. PubMed ID: 11279636 [TBL] [Abstract][Full Text] [Related]
60. Treatment of fungal diseases. A statement by the committee on therapy. Am Rev Respir Dis; 1969 Dec; 100(6):908-10. PubMed ID: 5357705 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]